Ichilov teams up with Boston’s Dana-Farber on cancer research

Credit: Photo: ליזי שאנן / PikiWiki Israel / CC BY 2.5

Tel Aviv Sourasky Medical Center (Ichilov) is launching a long-term partnership with Boston’s Dana-Farber Cancer Institute, one of the top three cancer centers in the United States. The collaboration will include joint research, exchanges of physicians and researchers, fellowship tracks, clinical cooperation and training programs.

In its first phase, the partnership will focus on three areas: breast cancer, early cancer detection and artificial intelligence in oncology.

Dana-Farber, which is affiliated with Harvard Medical School, runs more than 1,200 active clinical trials and sees tens of thousands of new patients every year.

Ahead of the launch, Dana-Farber president and CEO Prof. Benjamin Ebert and Adam Reich, senior vice president for business strategy, visited Ichilov. They met with hospital director Prof. Eli Sprecher, Prof. Ido Wolf and senior oncology staff, and were briefed on the AI work of I-NEXT Data, led by Liat Arad, and on the hematology division headed by Prof. Irit Avivi.

On November 10, a senior Ichilov delegation led by Sprecher, including oncology researchers and physicians and members of its research and innovation teams, left for Boston for the partnership’s official launch at Dana-Farber.

More information is available on the Ichilov website.

We aim to provide accurate, high-quality content only.
If you spotted inaccurate or incorrect information – we want to know. Please contact us and we’ll fix the issue promptly.

More articles you might find interesting: